ABO and thalassemia: Recommendation 4: Patients with thalassaemia who do not have any known alloantibody(ies) should be transfused with ABO, RhD, RhCcEe, and K‐matched RBCs to reduce the risk of alloimmunisation and delayed HTRs (low quality of evidence, weak recommendation).